Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan in 2016

Nav

General Info

Geography

Taiwan (Province of China) (TWN)

Coverage type

Country

Time period covered

01/2016 - 12/2016

Data type

Scientific literature

Keywords

Drug resistance, E. coli, Intensive care units, Klebsiella pneumoniae infection

Citation

Authors

Liao CH, Lee NY, Tang HJ, Lee SS, Lin CF, Lu PL, Wu JJ, Ko WC, Lee WS, Hsueh PR

Journal

Infect Drug Resist

Volume

Issue

Pages

545-552

Publication year

2019

Suggested citation

Liao CH, Lee NY, Tang HJ, Lee SS, Lin CF, Lu PL, Wu JJ, Ko WC, Lee WS, Hsueh PR. Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan in 2016. Infect Drug Resist. 2019; 12(1): 545-552.

DOI

102147IDRS193638

PMID

30881060

GHDx Entry last modified on: Sep 17, 2024

Header sites

Search form

Main menu

Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan in 2016

Nav